Major Pharmaceuticals Announces Change in Executive Leadership
Livonia, MI (July 30, 2010): Major Pharmaceuticals, a leading national supplier of generic over the counter pharmaceuticals, today announced that Michael Redd will step down as President on August 6, 2010 for personal reasons. Redd will be succeeded by Thomas Larkin, formerly Chief Strategic Officer of The Harvard Drug Group, parent company of Major Pharmaceuticals.
Major Announces Leadership Change (58 KB)